Conditions: Colorectal Cancer
Keywords: MB-6 FOLFOX4 Metastatic Colorectal Cancer
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 72
Healthy volunteers: no

Brief summary:
This is a randomized, double-blind, parallel group, placebo-controlled study evaluate the preliminary efficacy and safety of MB-6 (320 mg/capsule, 6 capsules tid) versus placebo in addition to standard chemotherapy in the treatment of patients with metastatic colorectal cancer.

Detailed description:

Arms:
arm 1: MB-6 6 capsules tid be taken with meals plus FOLFOX4, will be given for 16 weeks arm 2: Placebo, 6 capsules tid be taken with meals plus FOLFOX4, will be given for 16 weeks

Interventions: intervention 1: MB-6 intervention 2: Placebo
Intervention descriptions: intervention 1: 6# TID with meal intervention 2: 6# TID with meal

Protocol document: